Sun Pharma gets FDA nod for torsemide tablets
Sun Pharmaceutical Industries Ltd has received approval from the US Food and Drug Administration for torsemide tablets in multiple strengths.
By PTI |
MUMBAI: Sun Pharmaceutical Industries Ltd has received approval from the US Food and Drug Administration for torsemide tablets in multiple strengths, the Indian drug maker said.
The drug, a generic version of Hoffman-La Roche's Demadex, is indicated in the treatment of edema associated with congestive heart failure and renal disease, it said in a statement late on Wednesday.
The 5 mg, 10 mg, 20 mg and 100 mg dosages for which it has received approval had annual sales of about $35 million, it said.
The drug, a generic version of Hoffman-La Roche's Demadex, is indicated in the treatment of edema associated with congestive heart failure and renal disease, it said in a statement late on Wednesday.
The 5 mg, 10 mg, 20 mg and 100 mg dosages for which it has received approval had annual sales of about $35 million, it said.
Start a SIP with as low as ₹500 with ET Money App!
Download
The Economic Times News App for Quarterly Results, Latest News in ITR, Business, Share Market, Live Sensex News & More.
The Economic Times News App for Quarterly Results, Latest News in ITR, Business, Share Market, Live Sensex News & More.
ADVERTISEMENT
